US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
EP1862164A3
(de)
*
|
1998-11-13 |
2012-12-26 |
Jagotec AG |
Trockenpulver zur Inhalation
|
US20070212422A1
(en)
*
|
1999-11-10 |
2007-09-13 |
Manfred Keller |
Dry powder for inhalation
|
DZ2947A1
(fr)
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
IT1309592B1
(it)
|
1999-03-05 |
2002-01-24 |
Chiesi Farma Spa |
Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
|
DK1158958T3
(da)
*
|
1999-03-05 |
2007-10-08 |
Chiesi Farma Spa |
Forbedret pulverformulering til inhalering
|
US7258850B2
(en)
*
|
1999-05-04 |
2007-08-21 |
Aradigm Corporation |
Methods and compositions for treating erectile dysfunction
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
ITMI991582A1
(it)
|
1999-07-16 |
2001-01-16 |
Chiesi Farma Spa |
Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
|
IT1313553B1
(it)
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
DE19947235A1
(de)
*
|
1999-09-30 |
2001-04-05 |
Asta Medica Ag |
Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
|
WO2001026630A1
(fr)
*
|
1999-10-12 |
2001-04-19 |
Kaken Pharmaceutical Co., Ltd. |
Preparations pour inhalation en poudre et leur procede de production
|
IT1317720B1
(it)
*
|
2000-01-07 |
2003-07-15 |
Chiesi Farma Spa |
Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
|
IT1317846B1
(it)
*
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
GB0008660D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
GB0009468D0
(en)
*
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formulations for use in inhaler devices
|
PE20011227A1
(es)
*
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
GB0009469D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formalities for use in inhaler devices
|
ES2288167T3
(es)
*
|
2000-04-17 |
2008-01-01 |
Vectura Limited |
Formulaciones para usar en dispositivos inhaladores.
|
IT1318514B1
(it)
*
|
2000-05-12 |
2003-08-27 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
|
GB0012260D0
(en)
|
2000-05-19 |
2000-07-12 |
Astrazeneca Ab |
Novel composition
|
GB0012261D0
(en)
|
2000-05-19 |
2000-07-12 |
Astrazeneca Ab |
Novel process
|
HU230804B1
(hu)
*
|
2000-05-22 |
2018-06-28 |
Chiesi Farmaceutici S.P.A |
Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére
|
US7744855B2
(en)
*
|
2000-06-27 |
2010-06-29 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
JP5698423B2
(ja)
*
|
2000-06-27 |
2015-04-08 |
ベクトゥラ・リミテッド |
医薬組成物で使用するための粒子の製造法
|
ES2227268T3
(es)
*
|
2000-10-12 |
2005-04-01 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG |
Nuevos polvos para inhalacion con contenido en tiotropio.
|
UA75375C2
(en)
|
2000-10-12 |
2006-04-17 |
Boehringer Ingelheim Pharma |
Method for producing powdery preparations for inhaling
|
US20020183292A1
(en)
*
|
2000-10-31 |
2002-12-05 |
Michel Pairet |
Pharmaceutical compositions based on anticholinergics and corticosteroids
|
ES2689704T3
(es)
|
2000-11-30 |
2018-11-15 |
Vectura Limited |
Partículas para usar en una composición farmacéutica
|
ATE382335T1
(de)
|
2000-11-30 |
2008-01-15 |
Vectura Ltd |
Verfahren zur vorbereitung von mikropartikeln zur verwendung in pharmazeutischen zusammensetzungen zur inhalation
|
AU2002222115B2
(en)
†
|
2000-11-30 |
2006-09-28 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
GB0107106D0
(en)
*
|
2001-03-21 |
2001-05-09 |
Boehringer Ingelheim Pharma |
Powder inhaler formulations
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
WO2003026631A1
(en)
*
|
2001-05-24 |
2003-04-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
US20030051728A1
(en)
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
CA2446904A1
(en)
|
2001-05-24 |
2003-04-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
US20030013675A1
(en)
*
|
2001-05-25 |
2003-01-16 |
Boehringer Ingelheim Pharma Kg |
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
|
DE10126924A1
(de)
*
|
2001-06-01 |
2002-12-05 |
Boehringer Ingelheim Pharma |
Inhalationskapseln
|
US20030070679A1
(en)
*
|
2001-06-01 |
2003-04-17 |
Boehringer Ingelheim Pharma Kg |
Capsules containing inhalable tiotropium
|
DE10130371A1
(de)
*
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
|
ATE267591T1
(de)
*
|
2001-07-02 |
2004-06-15 |
Chiesi Farma Spa |
Optimierte tobramycin-formulierung zur aerosolbildung
|
JP2004537377A
(ja)
*
|
2001-08-09 |
2004-12-16 |
グラクソ グループ リミテッド |
製薬組成物を有する吸入装置
|
WO2003024396A2
(en)
*
|
2001-09-17 |
2003-03-27 |
Glaxo Group Limited |
Dry powder medicament formulations
|
JP2005523905A
(ja)
*
|
2002-03-01 |
2005-08-11 |
キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ |
ホルモテロール(formoterol)超微細調合物
|
DE10212264A1
(de)
*
|
2002-03-20 |
2003-10-02 |
Boehringer Ingelheim Pharma |
Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
|
WO2003084509A1
(en)
*
|
2002-04-04 |
2003-10-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder formulations suitable for inhalation
|
UA80123C2
(en)
*
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
US20030235538A1
(en)
*
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
EP1553954A4
(en)
*
|
2002-06-17 |
2009-12-23 |
Epigenesis Pharmaceuticals Llc |
DIHYDRATE DEHYDROEPIANDROSTERONE AND METHOD FOR THE TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE LUNG DISEASE, COMPOSITIONS THEREOF
|
US7078423B2
(en)
|
2002-07-18 |
2006-07-18 |
Inotek Pharmaceuticals Corporation |
5-Aryltetrazole compounds, compositions thereof, and uses therefor
|
US7087631B2
(en)
|
2002-07-18 |
2006-08-08 |
Inotek Pharmaceuticals Corporation |
Aryltetrazole compounds, and compositions thereof
|
MXPA05001903A
(es)
*
|
2002-08-21 |
2005-04-28 |
Norton Healthcare Ltd |
Composicion para inhalacion.
|
GB0219511D0
(en)
*
|
2002-08-21 |
2002-10-02 |
Norton Healthcare Ltd |
Method of preparing dry powder inhalation compositions
|
GB0219513D0
(en)
*
|
2002-08-21 |
2002-10-02 |
Norton Healthcare Ltd |
Inhalation compositions including coarse carrier
|
JP2006516531A
(ja)
*
|
2002-08-21 |
2006-07-06 |
ノートン ヘルスケアー リミテッド |
吸入組成物
|
GB0219512D0
(en)
*
|
2002-08-21 |
2002-10-02 |
Norton Healthcare Ltd |
Inhalation compositions with high drug ratios
|
US20050158248A1
(en)
*
|
2002-08-21 |
2005-07-21 |
Xian-Ming Zeng |
Method of preparing dry powder inhalation compositions
|
NZ538493A
(en)
*
|
2002-08-29 |
2007-10-26 |
Cipla Ltd |
Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
|
SE0203376D0
(sv)
*
|
2002-11-15 |
2002-11-15 |
Astrazeneca Ab |
New process
|
US7763280B2
(en)
*
|
2002-11-28 |
2010-07-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing powder formulation for inhalation
|
DE10255387A1
(de)
*
|
2002-11-28 |
2004-06-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Tiotropium-haltige Pulverformulierung für die Inhalation
|
WO2004052835A1
(en)
*
|
2002-12-10 |
2004-06-24 |
Sepracor Inc. |
Levalbuterol salt
|
DE60323138D1
(de)
*
|
2002-12-12 |
2008-10-02 |
Nycomed Gmbh |
Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
|
US20040152720A1
(en)
*
|
2002-12-20 |
2004-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
|
US20060147389A1
(en)
*
|
2004-04-14 |
2006-07-06 |
Vectura Ltd. |
Devices and pharmaceutical compositions for enhancing dosing efficiency
|
US20120321717A1
(en)
*
|
2003-04-14 |
2012-12-20 |
Vectura Ltd. |
Devices and pharmaceutical compositions for enhancing dosing efficiency
|
CN102688224A
(zh)
*
|
2003-04-14 |
2012-09-26 |
维克特拉有限公司 |
用于提高剂量效率的药物组合物和装置
|
DE10317461A1
(de)
*
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
US20040234916A1
(en)
|
2003-05-21 |
2004-11-25 |
Alexza Molecular Delivery Corporation |
Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
|
US20060293293A1
(en)
*
|
2003-05-22 |
2006-12-28 |
Altana Pharma Ag |
Salmeterol and ciclesonide combination
|
GB0312148D0
(en)
*
|
2003-05-28 |
2003-07-02 |
Aventis Pharma Ltd |
Stabilized pharmaceutical products
|
SE526509C2
(sv)
*
|
2003-06-19 |
2005-09-27 |
Microdrug Ag |
Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
|
SE527190C2
(sv)
*
|
2003-06-19 |
2006-01-17 |
Microdrug Ag |
Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid
|
SE527069C2
(sv)
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
SE527200C2
(sv)
*
|
2003-06-19 |
2006-01-17 |
Microdrug Ag |
Inhalatoranordning samt kombinerade doser av formaterol och fluticason
|
SE526850C2
(sv)
*
|
2003-06-19 |
2005-11-08 |
Microdrug Ag |
Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd
|
SE527189C2
(sv)
*
|
2003-06-19 |
2006-01-17 |
Microdrug Ag |
Inhalatoranordning samt kombinerade doser för formaterol och ett antikolinergiskt medel
|
GB0315889D0
(en)
*
|
2003-07-08 |
2003-08-13 |
Aventis Pharma Ltd |
Stable pharmaceutical products
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
US20060210485A1
(en)
*
|
2003-07-11 |
2006-09-21 |
Marian Thomas |
Pharmaceutical formulations
|
EP1646370A1
(en)
*
|
2003-07-11 |
2006-04-19 |
Glaxo Group Limited |
Pharmaceutical formulations
|
GB0316341D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
EP1643973A1
(en)
*
|
2003-07-11 |
2006-04-12 |
Glaxo Group Limited |
Pharmaceutical formulations comprising magnesium stearate
|
GB0321607D0
(en)
*
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
ES2452691T5
(es)
*
|
2003-09-16 |
2022-09-14 |
Covis Pharma Gmbh |
Uso de ciclesonida para el tratamiento de enfermedades respiratorias
|
GB0323684D0
(en)
|
2003-10-09 |
2003-11-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
GB0324918D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
JP2007509941A
(ja)
*
|
2003-10-28 |
2007-04-19 |
グラクソ グループ リミテッド |
ラクトース無水物を用いる吸入医薬製剤およびその投与方法
|
WO2005041980A1
(en)
|
2003-11-03 |
2005-05-12 |
Ivax Corporation |
Soft steroid compositions for use in dry powder inhalers
|
DE10352277A1
(de)
*
|
2003-11-08 |
2005-06-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulverinhalator
|
GB0326632D0
(en)
*
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
SE0303270L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
WO2005053647A1
(en)
*
|
2003-12-03 |
2005-06-16 |
Microdrug Ag |
Medical product containing tiotropium
|
SE0303570L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
SE0303269L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Medicinsk produkt
|
US20060018970A1
(en)
*
|
2003-12-12 |
2006-01-26 |
Myogen, Inc. |
Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
|
JP5524442B2
(ja)
*
|
2004-02-06 |
2014-06-18 |
メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
呼吸器疾患の治療のための、抗コリン作用薬及びβ−模倣薬の新規併用薬
|
CN100512813C
(zh)
*
|
2004-02-06 |
2009-07-15 |
Meda制药有限及两合公司 |
用于呼吸道疾病治疗的抗胆碱能药和4型磷酸二酯酶抑制剂的组合
|
PT1713473E
(pt)
*
|
2004-02-06 |
2013-05-13 |
Meda Pharma Gmbh & Co Kg |
Combinação de anticolinérgicos e glucocorticóides para o tratamento a longo prazo de asma e copd
|
EP1595531A1
(en)
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
WO2005082413A2
(en)
*
|
2004-02-27 |
2005-09-09 |
Altana Pharma Ag |
Ciclesonide and glycopyrronium combination
|
CA2560538A1
(en)
*
|
2004-03-22 |
2005-10-06 |
Myogen, Inc. |
(r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
|
CA2560528A1
(en)
*
|
2004-03-22 |
2005-10-06 |
Myogen, Inc. |
(s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
|
JP2007533706A
(ja)
*
|
2004-04-20 |
2007-11-22 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
|
JP2007534693A
(ja)
|
2004-04-23 |
2007-11-29 |
サイデックス・インコーポレイテッド |
スルホアルキルエーテルシクロデキストリンを含有するdpi製剤
|
GB0409703D0
(en)
*
|
2004-04-30 |
2004-06-02 |
Vectura Ltd |
Pharmaceutical compositions
|
GB0410398D0
(en)
*
|
2004-05-10 |
2004-06-16 |
Arakis Ltd |
The treatment of respiratory disease
|
GB0410399D0
(en)
*
|
2004-05-10 |
2004-06-16 |
Arakis Ltd |
The treatment of respiratory disease
|
GB0411056D0
(en)
*
|
2004-05-18 |
2004-06-23 |
Novartis Ag |
Organic compounds
|
SE530006C2
(sv)
*
|
2004-06-18 |
2008-02-05 |
Mederio Ag |
Inhalator som använder balja
|
EP1776108A1
(en)
*
|
2004-06-23 |
2007-04-25 |
Myogen, Inc. |
Enoximone formulations and their use in the treatment of pde-iii mediated diseases
|
CA2579007A1
(en)
*
|
2004-09-10 |
2006-03-16 |
Altana Pharma Ag |
Ciclesonide and syk inhibitor combination and methods of use thereof
|
GB0425758D0
(en)
|
2004-11-23 |
2004-12-22 |
Vectura Ltd |
Preparation of pharmaceutical compositions
|
BRPI0519481A2
(pt)
|
2004-12-27 |
2009-02-03 |
Beiersdorf Ag |
glicopirrolato em preparaÇÕes cosmÉticas
|
JP3955868B2
(ja)
*
|
2004-12-27 |
2007-08-08 |
株式会社キングジム |
書類等の綴じ具
|
DE102005029385B4
(de)
*
|
2005-06-23 |
2018-12-27 |
Beiersdorf Ag |
Wirkstoffkombinationen aus Glycopyrroniumbromid und Chitosan
|
WO2006094924A2
(en)
*
|
2005-03-09 |
2006-09-14 |
Boehringer Ingelheim International Gmbh |
New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
|
SI1863476T1
(sl)
*
|
2005-03-16 |
2016-05-31 |
Meda Pharma Gmbh & Co. Kg |
Kombinacija antiholinergikov in antagonistov receptorja levkotriena za zdravljenje respiratornih bolezni
|
EP2484382A1
(en)
*
|
2005-03-30 |
2012-08-08 |
Schering Corporation |
Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form
|
US20060239935A1
(en)
*
|
2005-04-23 |
2006-10-26 |
Boehringer Ingelheim International Gmbh |
Compositions for inhalation
|
JP2008538758A
(ja)
*
|
2005-04-23 |
2008-11-06 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
抗コリン作用薬に加えてベータ受容体刺激薬及びステロイドを含有する吸入用の医薬組成物
|
TWI274641B
(en)
*
|
2005-08-30 |
2007-03-01 |
Rexon Ind Corp Ltd |
Cutting machine
|
GB0520794D0
(en)
*
|
2005-10-12 |
2005-11-23 |
Innovata Biomed Ltd |
Inhaler
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
GB0525254D0
(en)
*
|
2005-12-12 |
2006-01-18 |
Jagotec Ag |
Powder compositions for inhalation
|
AU2012200449B2
(en)
*
|
2005-12-21 |
2013-07-25 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases
|
ES2389231T3
(es)
|
2005-12-21 |
2012-10-24 |
Meda Pharma Gmbh & Co. Kg |
Combinación de anticolinérgicos, glucocorticoides y agonistas de beta2 para el tratamiento de enfermedades inflamatorias
|
EP1803457A1
(en)
*
|
2005-12-30 |
2007-07-04 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Pharmaceutical composition containing montelukast
|
EA021960B1
(ru)
*
|
2005-12-30 |
2015-10-30 |
Крка, Товарна Здравил, Д.Д., Ново Место |
Таблетка, содержащая фармацевтически приемлемую соль монтелукаста в аморфной форме, и способ ее получения
|
GB0602897D0
(en)
*
|
2006-02-13 |
2006-03-22 |
Jagotec Ag |
Improvements In Or Relating To Dry Powder Inhaler Devices
|
GB0606124D0
(en)
|
2006-03-28 |
2006-05-03 |
Reckitt Benckiser Healthcare |
Buprenorphine derivatives and uses thereof
|
GB0613161D0
(en)
|
2006-06-30 |
2006-08-09 |
Novartis Ag |
Organic Compounds
|
JP2009545579A
(ja)
|
2006-08-01 |
2009-12-24 |
グラクソ グループ リミテッド |
ピラゾロ[3,4−b]ピリジン化合物、及びpde4阻害薬としてのその使用
|
RU2338552C2
(ru)
*
|
2006-09-19 |
2008-11-20 |
Владимир Евгеньевич Небольсин |
Фармацевтическая композиция для ингаляции
|
GB0622818D0
(en)
*
|
2006-11-15 |
2006-12-27 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
GB0625303D0
(en)
*
|
2006-12-19 |
2007-01-24 |
Jagotec Ag |
Improvements in and relating to metered dose inhalers
|
US20080216828A1
(en)
|
2007-03-09 |
2008-09-11 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
US8415390B2
(en)
|
2008-05-30 |
2013-04-09 |
Microdose Therapeutx, Inc. |
Methods and compositions for administration of oxybutynin
|
US9119777B2
(en)
|
2008-05-30 |
2015-09-01 |
Microdose Therapeutx, Inc. |
Methods and compositions for administration of oxybutynin
|
GB0716026D0
(en)
*
|
2007-08-16 |
2007-09-26 |
Norton Healthcare Ltd |
An inhalable medicament
|
EP2328556A4
(en)
*
|
2008-07-30 |
2013-11-20 |
Stc Unm |
FORMULATIONS WITH LARGE SUPPORT PARTS FOR AEROSOLS FOR THE INHALATION OF DRY POWDER
|
EP2172190A1
(en)
*
|
2008-10-02 |
2010-04-07 |
Laboratorios Liconsa, S.A. |
Inhalable particles comprising tiotropium
|
JP2012509922A
(ja)
*
|
2008-11-27 |
2012-04-26 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規粉末化結晶質吸入薬
|
EP2201977A1
(de)
|
2008-12-23 |
2010-06-30 |
Siegfried Generics International AG |
Dosiervorrichtung zur Erzeugung eines Gasstromes mit einem in diesem fein verteilten Wirkstoff
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
EP2400950B1
(en)
|
2009-02-26 |
2019-05-22 |
Glaxo Group Limited |
Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
US9463161B2
(en)
*
|
2009-05-29 |
2016-10-11 |
Pearl Therapeutics, Inc. |
Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems
|
AU2010260513A1
(en)
*
|
2009-06-16 |
2012-02-02 |
Wen Tan |
Use of R-Bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
|
AU2009100698B4
(en)
*
|
2009-07-17 |
2010-04-15 |
Astrazeneca Ab |
Combination
|
GB0918149D0
(en)
|
2009-10-16 |
2009-12-02 |
Jagotec Ag |
Improved medicinal aerosol formulation
|
GB0918249D0
(en)
|
2009-10-19 |
2009-12-02 |
Respivert Ltd |
Compounds
|
GB0918450D0
(en)
|
2009-10-21 |
2009-12-09 |
Innovata Ltd |
Composition
|
US9433588B2
(en)
|
2009-11-09 |
2016-09-06 |
Virginia Commonwealth Univeristy |
Delivery of submicrometer and nanometer aerosols to the lungs using hygroscopic excipients or dual stream nasal delivery
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
CN102695496B
(zh)
*
|
2009-12-23 |
2014-10-01 |
奇斯药制品公司 |
用于copd的气雾剂制剂
|
TR201000679A2
(tr)
*
|
2010-01-29 |
2011-08-22 |
B�Lg�� Mahmut |
Farmasötik bir kombinasyon içeren kuru toz formülasyonları.
|
US8834931B2
(en)
|
2009-12-25 |
2014-09-16 |
Mahmut Bilgic |
Dry powder formulation containing tiotropium for inhalation
|
MY162391A
(en)
*
|
2010-04-01 |
2017-06-15 |
Chiesi Farm Spa |
Process for preparing carrier particles for dry powders for inhalation
|
JP5913289B2
(ja)
*
|
2010-04-21 |
2016-04-27 |
シエシー ファルマセウティチィ ソシエタ ペル アチオニ |
帯電を低減した粒子を提供する方法
|
US20130177651A1
(en)
|
2010-09-03 |
2013-07-11 |
Pharmaterials Limited |
Pharmaceutical Composition Suitable for Use in a Dry Powder Inhaler
|
KR101886987B1
(ko)
*
|
2010-09-30 |
2018-08-08 |
키에시 파르마슈티시 엣스. 피. 에이. |
흡입용 건조 분말 제제 내 마그네슘 스테아레이트의 용도
|
UY33337A
(es)
|
2010-10-18 |
2011-10-31 |
Respivert Ltd |
DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
|
JO3510B1
(ar)
|
2011-03-04 |
2020-07-05 |
Heptares Therapeutics Ltd |
استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
|
EA037797B1
(ru)
|
2011-10-25 |
2021-05-21 |
Протена Байосайенсиз Лимитед |
Состав антитела, пригодный для профилактики и лечения амилоидоза, его варианты и способ его получения
|
GB201200525D0
(en)
|
2011-12-19 |
2012-02-29 |
Teva Branded Pharmaceutical Prod R & D Inc |
An inhalable medicament
|
BR112014017481A8
(pt)
*
|
2012-01-25 |
2021-06-15 |
Chiesi Farm Spa |
formulação em pó seco para uso em um inalador de pó seco, inalador de pó seco e uso de uma formulação
|
US9603907B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Dry powder formulations of dNase I
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
ES2600705T3
(es)
|
2012-03-13 |
2017-02-10 |
Respivert Limited |
Inhibidores de PI3 cinasa cristalinos
|
EP2641900A1
(en)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
|
RU2494730C1
(ru)
*
|
2012-03-27 |
2013-10-10 |
Шолекс Девелопмент Гмбх |
Ингаляционный препарат для лечения болезней органов дыхания, содержащий в качестве активных веществ микронизированный салметерол ксинофоат и микронизированный флутиказона пропионат и способ его получения
|
EP2836204B1
(en)
|
2012-04-13 |
2020-07-08 |
GlaxoSmithKline Intellectual Property Development Limited |
Aggregate particles
|
US10105316B2
(en)
|
2012-07-05 |
2018-10-23 |
Arven llac Sanayi Ve Ticaret A.S. |
Inhalation compositions comprising muscarinic receptor antagonist
|
US20150202297A1
(en)
*
|
2012-07-05 |
2015-07-23 |
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi |
Dry powder inhalers comprising a carrier other than lactose and a ternary component
|
US10111957B2
(en)
|
2012-07-05 |
2018-10-30 |
Arven Ilac Snayi ve Ticaret A.S. |
Inhalation compositions comprising glucose anhydrous
|
US20150202148A1
(en)
|
2012-07-05 |
2015-07-23 |
Arven llac Sanayi Ve Ticaret Anonim Sirketi |
Dry powder inhalers comprising a carrier other than lactose
|
US9452139B2
(en)
|
2013-03-14 |
2016-09-27 |
Novartis Ag |
Respirable agglomerates of porous carrier particles and micronized drug
|
JP6454323B2
(ja)
|
2013-03-15 |
2019-01-16 |
パール セラピューティクス,インコーポレイテッド |
粒子状結晶性材料のコンディショニングのための方法及びシステム
|
GB201305825D0
(en)
|
2013-03-28 |
2013-05-15 |
Vectura Ltd |
New use
|
EP2821061B1
(en)
*
|
2013-07-01 |
2017-12-20 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Novel inhalation formulations
|
LT3409270T
(lt)
|
2013-07-11 |
2021-07-26 |
Chiesi Farmaceutici S.P.A. |
Sausų miltelių kompozicija, apimanti anticholinerginį agentą, kortikosteroidą ir beta adrenerginį agentą, skirta vartoti įkvepiant
|
EP3060205A4
(en)
*
|
2013-10-22 |
2017-06-28 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
CN104644618A
(zh)
*
|
2013-11-19 |
2015-05-27 |
上海医药工业研究院 |
一种干粉吸入剂及其制备方法
|
GB201321712D0
(en)
*
|
2013-12-09 |
2014-01-22 |
Pharmachemie Bv |
Dry Powder Inhaler
|
JP6672258B2
(ja)
*
|
2014-04-08 |
2020-03-25 |
フィリップ・モーリス・プロダクツ・ソシエテ・アノニム |
ニコチン製剤及びその作製方法
|
US10034866B2
(en)
|
2014-06-19 |
2018-07-31 |
Teva Branded Pharmaceutical Products R&D, Inc. |
Inhalable medicament comprising tiotropium
|
EA201692456A1
(ru)
*
|
2014-07-09 |
2017-08-31 |
Арвен Иладж Санайи Ве Тиджарет А.Ш. |
Способ получения составов для ингаляции
|
AU2015338717B2
(en)
|
2014-10-31 |
2018-12-20 |
Glaxosmithkline Intellectual Property Development Limited |
Powder formulation
|
JP2018501903A
(ja)
|
2015-01-14 |
2018-01-25 |
レスピラ セラピューティクス インコーポレイテッドRespira Therapeutics,Inc. |
パウダー分散方法および装置
|
WO2017077488A1
(en)
*
|
2015-11-04 |
2017-05-11 |
Glenmark Pharmaceuticals Limited |
An inhalable fixed dose powder composition comprising glycopyrronium and formoterol
|
WO2017168174A1
(en)
|
2016-04-02 |
2017-10-05 |
N4 Pharma Uk Limited |
New pharmaceutical forms of sildenafil
|
TWI745396B
(zh)
*
|
2016-07-12 |
2021-11-11 |
日商鹽野義製藥股份有限公司 |
吸入用醫藥組成物
|
CA3033079A1
(en)
|
2016-08-31 |
2018-03-08 |
The General Hospital Corporation |
Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
|
ES2882153T3
(es)
*
|
2017-05-11 |
2021-12-01 |
Chiesi Farm Spa |
Un proceso para preparar una formulación en polvo seco que comprende un anticolinérgico, un corticosteroide y un betaadrenérgico
|
CN108175764B
(zh)
*
|
2017-12-19 |
2020-02-21 |
亿腾医药(苏州)有限公司 |
一种无水二丙酸倍氯米松无菌粉末及其吸入混悬液的制备方法
|
EP3673895A1
(en)
*
|
2018-12-28 |
2020-07-01 |
Université Libre de Bruxelles |
Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
|
CN113476428B
(zh)
*
|
2021-01-28 |
2022-03-29 |
朗天药业(湖北)有限公司 |
一种吸入用硫酸沙丁胺醇溶液及其制备方法
|
GR1010358B
(el)
*
|
2021-09-14 |
2022-12-16 |
Elpen Ανωνυμος Εταιρεια Φαρμακευτικη Βιομηχανια, |
Σταθερο φαρμακευτικο σκευασμα που περιεχει βρωμιουχο τιοτροπιο, για χορηγηση απο το αναπνευστικο
|
WO2023117967A1
(en)
|
2021-12-21 |
2023-06-29 |
Chiesi Farmaceutici S.P.A. |
Dry powder formulations filled in an inhaler with improved resistance to humidity
|
WO2023117985A1
(en)
|
2021-12-21 |
2023-06-29 |
Chiesi Farmaceutici S.P.A. |
Dry powder formulations filled in an inhaler with improved resistance to humidity
|